Fanconi Anemia: Clinical Trials

30 trials for Fanconi Anemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 8 terminated, 3 recruiting, 2 unknown. 30 Phase 1, 17 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 130Completed 15, Terminated 8, Recruiting 3, Unknown 2, Not yet recruiting 1, Withdrawn 1
Phase 217Completed 8, Terminated 5, Recruiting 2, Not yet recruiting 1, Withdrawn 1

Follow Fanconi Anemia: new trials by email Literature Review of Fanconi Anemia trials Research Report on Fanconi Anemia

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prenatal Transplantation for Fetuses With Fanconi Anemia
IUHSCT for FA-affected fetuses - Fanconi Anemia, Anemia, Hypoplastic, Congenital
Phase 1 / Phase 2Not yet recruitingAgnieszka Czechowicz122028-01-012026-06-16
Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia
Metformin, Naproxen Sodium - Fanconi Anemia, Head and Neck Cancer
Phase 1RecruitingRockefeller University802026-10-142026-10-28
Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Afatinib - Fanconi Anemia, Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau252024-11-082026-05-27
A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia
FP-045 - Fanconi Anemia
Phase 1 / Phase 2WithdrawnForesee Pharmaceuticals Co., Ltd.2023-06-302025-03-06
Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
JSP191, CliniMACS Prodigy System, Depleted Stem Cell Transplant - Fanconi Anemia
Phase 1 / Phase 2RecruitingPorteus, Matthew, MD182021-12-072026-01-27
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor
G-CSF, Plerixafor - Fanconi Anemia
Phase 1 / Phase 2CompletedAssistance Publique - Hôpitaux de Paris42017-02-102025-09-11
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Rimiducid, rivogenlecleucel - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2TerminatedBellicum Pharmaceuticals1872017-01-012023-09-26
A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer
SRA737 - Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Phase 1 / Phase 2CompletedSierra Oncology LLC - a GSK company1072016-07-012023-06-18
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
SRA737, gemcitabine, cisplatin, SRA737, gemcitabine - Advanced Solid Tumors
Phase 1 / Phase 2CompletedSierra Oncology LLC - a GSK company1532016-07-012023-06-22
Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A
IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs), Genetically Engineered Hematopoietic Stem/Progenitor Cells, Laboratory Biomarker Analysis - Fanconi Anemia
Phase 1 / Phase 2CompletedHospital Infantil Universitario Niño Jesús, Madrid, Spain92016-01-072024-03-21
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
BPX-501 and Rimiducid - Primary Immune Deficiency Disorders, Hemophagocytic Lymphohistiocytosis
Phase 1TerminatedBellicum Pharmaceuticals12015-02-012024-03-25
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2TerminatedBellicum Pharmaceuticals1872014-04-012023-09-29
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
Abatacept - Hurler Syndrome, Fanconi Anemia
Phase 1CompletedEmory University102014-01-012019-12-26
Quercetin in Children With Fanconi Anemia; a Pilot Study
Quercetin (dietary supplement) - Fanconi Anemia
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati302012-07-012024-01-18
Gene Therapy for Fanconi Anemia
Bone Marrow Aspiration, Filgrastim, Genetically Engineered Hematopoietic Stem Progenitor Cells - Fanconi Anemia
Phase 1TerminatedFred Hutchinson Cancer Center32012-02-222024-05-17
Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita
danazol - Fanconi Anemia, Dyskeratosis Congenita
Phase 1 / Phase 2TerminatedBoston Children's Hospital52009-11-012019-02-19
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100
AMD3100, AmCell CliniMACs - Fanconi Anemia
Phase 1 / Phase 2CompletedChildren's Hospital Medical Center, Cincinnati12007-05-012020-10-30
Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia
Retrovirus Construct - Fanconi Anemia
Phase 1CompletedBoston Children's Hospital32004-08-012017-06-23
Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
Oxandrolone - Fanconi Anemia
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati102004-07-012011-07-15
Stem Cell Transplantation for Fanconi Anemia
Hematopoietic Stem Cell Transplant, Thymic Shielding During Radiation, Total Body Irradiation - Fanconi Anemia
Phase 1 / Phase 2TerminatedMasonic Cancer Center, University of Minnesota162004-03-012019-08-26

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Anemia, Aplastic (6)  ·  Anemia, Diamond-Blackfan (5)  ·  Anemia, Sickle Cell (4)  ·  Anemia (3)  ·  Dyskeratosis Congenita (3)  ·  Hemoglobinopathies (3)  ·  Leukemia (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Primary Immunodeficiency Diseases (3)  ·  Thalassemia (3)  ·  Bone Marrow Failure Disorders (2)  ·  Congenital Bone Marrow Failure Syndromes (2)  ·  Cytopenia (2)  ·  Granulomatous Disease, Chronic (2)

Broader conditions

Bone Marrow Diseases (30)  ·  Hemic and Lymphatic Diseases (30)  ·  Nutritional and Metabolic Diseases (30)  ·  Anemia, Hypoplastic, Congenital (29)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (29)  ·  DNA Repair-Deficiency Disorders (29)  ·  Genetic Diseases, Inborn (29)  ·  Metabolic Diseases (29)  ·  Bone Marrow Failure Disorders (28)  ·  Congenital Bone Marrow Failure Syndromes (28)  ·  Hematologic Diseases (28)  ·  Anemia (27)  ·  Anemia, Aplastic (24)  ·  Neoplasms (7)  ·  Neoplasms by Histologic Type (7)

Interventions

Cyclophosphamide (5)  ·  Filgrastim (5)  ·  fludarabine (5)  ·  Cyclosporine (4)  ·  Granulocyte Colony-Stimulating Factor (4)  ·  fludarabine phosphate (4)  ·  plerixafor (4)  ·  Antilymphocyte Serum (3)  ·  Methylprednisolone (3)  ·  AP 1903 reagent (2)  ·  Alemtuzumab (2)  ·  Mycophenolic Acid (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Radiotherapy (2)  ·  SRA737 (2)

Sponsors

Bellicum Pharmaceuticals (3)  ·  Children's Hospital Medical Center, Cincinnati (3)  ·  Fred Hutchinson Cancer Center (3)  ·  Baylor College of Medicine (2)  ·  Boston Children's Hospital (2)  ·  Masonic Cancer Center, University of Minnesota (2)  ·  Sierra Oncology LLC - a GSK company (2)  ·  University of Minnesota (2)  ·  Agnieszka Czechowicz (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Dana-Farber Cancer Institute (1)  ·  Emory University (1)  ·  Foresee Pharmaceuticals Co., Ltd. (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Hospital Infantil Universitario Niño Jesús, Madrid, Spain (1)

Countries

United States (21)  ·  Spain (3)  ·  United Kingdom (3)  ·  Italy (2)  ·  Brazil (1)  ·  France (1)  ·  Germany (1)

Top investigators

Hans-Peter Kiem (2)  ·  John E. Wagner, Jr. (2)  ·  Agata Smogorzewska, MD, PhD (1)  ·  Colin A Sieff, MB.BCh (1)  ·  Franklin O Smith, M.D. (1)  ·  Franklin O. Smith, MD (1)  ·  Hans-Peter Kiem, MD (1)  ·  John T Horan, MD (1)  ·  Juan A Bueren (1)  ·  Malcolm Brenner, M.B., Ph.D., (1)  ·  Malcolm Brenner, MB, PhD (1)  ·  Margaret L. MacMillan, MD (1)

Results publications

PMID 25824692, PMID 31501599, PMID 34665631, PMID 34751952, PMID 36378548, PMID 37120671, PMID 37142543, PMID 39642902, PMID 39820512, PMID 40696207, PMID 40859225

NIH funding

R01HL081499 (2), 2014 (1), P30CA015704 (1)